Clinical Trial Detail

NCT ID NCT02451423
Title Study of MPDL3280A in Bladder Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

bladder urothelial carcinoma

Therapies

Atezolizumab

Age Groups: adult

No variant requirements are available.